Sanctuary Advisors »

BioCryst Pharmaceuticals shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $111k 27k 4.16

More positions owned by Sanctuary Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Total Usd (IUSB)
Exxon Mobil Corporation (XOM)

View all positions for Sanctuary Advisors

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals